NOD2/CARD15 variants of donor and recipient as critical risk factors for the development of bronchiolitis obliterans syndrome after allogeneic stem cell transplantation.

被引：0
|
作者：
Hildebrandt, G
Wolff, D
Hertenstein, B
Greinix, HT
Rogler, G
Brenmoehl, J
Schulz, C
Dickinson, AM
Andreesen, R
Holler, E
机构：
[1] Univ Regensburg, Dept Hematol, D-8400 Regensburg, Germany
[2] Univ Rostock, Dept Hematol, Rostock, Germany
[3] Hannnover Med Univ, Dept Hematol, Hannover, Germany
[4] Vienna Med Univ, Dept Internal Med 1, Vienna, Austria
[5] Univ Regensburg, Dept Internal Med, D-8400 Regensburg, Germany
[6] Univ Regensburg, Dept Pulm, D-8400 Regensburg, Germany
[7] Royal Victoria Infirm, Dept Hematol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
144
引用
收藏
页码：46A / 46A
页数：1
相关论文
共 50 条
  • [1] Recipient NOD2/CARD15 variants:: A novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation
    Hildebrandt, Gerhard C.
    Granell, Miguell
    Urbano-Lspizua, Alvaro
    Wolff, Daniel
    Hertenstein, Bernd
    Greinix, Hildegard T.
    Brenmoehl, Julia
    Schulz, Christian
    Dickinson, Anne M.
    Hahn, Joachim
    Rogler, Gerhard
    Andreesen, Reinhard
    Holler, Ennst
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (01) : 67 - 74
  • [2] Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: The effect of NOD2/CARD15 mutations in a Tunisian population
    Touihri, Mouna
    Torjeman, Lamia
    Kaabi, Houda
    Chabaane, Manel
    Ben Othman, Tarek
    Hmida, Slama
    HUMAN IMMUNOLOGY, 2019, 80 (03) : 163 - 168
  • [3] NOD2/CARD15 Variants Are Not a Risk Factor for Clinical Outcome after Nonmyeloablative Allogeneic Stem Cell Transplantation
    van der Straaten, Hanneke M.
    Paquay, Martine M.
    Tilanus, Marcel G. J.
    van Geloven, Nan
    Verdonck, Leo F.
    Huisman, Cynthia
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (08) : 1231 - 1236
  • [4] SNP12 and SNP13 variants of NOD2/CARD15 gene of donor and recipient as independent risk factors for severe intestinal and pulmonary GVHD after allogeneic hematopoietic stem cell transplantation.
    Holowiecka-Goral, Alexandra
    Wojnar, Jerzy
    Giebel, Sebastian
    Grudziecka, Elzbieta
    Oczko, Malgorzata
    Jarzab, Barbara
    Sankowska, Monika
    BLOOD, 2006, 108 (11) : 925A - 925A
  • [5] NOD2/CARD15 gene variants and GVHD after allogeneic hematopoietic stem cell transplantation: pilot study
    Ambruzova, Z.
    Mrazek, F.
    Raida, L.
    Faber, E.
    Onderkova, J.
    Kriegova, E.
    Indrak, K.
    Petrek, M.
    TISSUE ANTIGENS, 2007, 69 (05): : 515 - 515
  • [6] NOD2/CARD15 variants are a risk factor for lung complications after stem cell transplantation (SCT)
    Brenmoehl, Julia
    Hildebrandt, Gerhard
    Wolff, Daniel
    Hertenstein, Bernd
    Greinix, Hildegard T.
    Schulz, Christian
    Dickinson, Anne M.
    Schoelmerich, Juergen
    Andreesen, Reinhard
    Rogler, Gerhard
    Holler, Ernst
    GASTROENTEROLOGY, 2006, 130 (04) : A589 - A589
  • [7] Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation
    Granell, Miguel
    Urbano-Ispizua, Alvaro
    Ignacio Arostegui, Juan
    Fernandez-Aviles, Francesc
    Martinez, Carmen
    Rovira, Montserrat
    Rius, Josefa
    Plaza, Susana
    Gaya, Anna
    Navarro, Alfons
    Talarn, Carme
    Carreras, Enric
    Monzo, Mariano
    Montserrat, Emili
    Yague, Jordi
    HAEMATOLOGICA, 2006, 91 (10) : 1372 - 1376
  • [8] NOD2/CARD15 VARIANTS ARE NOT A RISK FACTOR FOR CLINICAL OUTCOME AFTER NON-MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION
    van der Straaten, H.
    Paquay, M.
    Tilanus, M.
    van Geloven, N.
    Verdonck, L.
    Huisman, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 647 - 647
  • [9] Prognostic significance of NOD2/CARD15 variants in haematopoietic stem cell transplantation
    Reddiconto, G.
    Giammarco, S.
    Farina, G.
    Fiorini, A.
    Marietti, S.
    Palladino, M.
    Tarnani, M.
    Leone, G.
    Chiusolo, P.
    Sica, S.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S225 - S225
  • [10] No direct effect of NOD2/CARD15 variants on clinical outcome after non-myeloablative allogeneic stem cell transplantation
    van der Straaten, H. M.
    Paquay, M. M.
    Tilanus, M. G. J.
    van Geloven, N.
    Verdonck, L. F.
    Huisman, C.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S287 - S288
12345